2026 Spring Symposium
Flex Your Knowledge: Muscle in Cerebral Palsy from Basic Science to Clinical Application
The American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) is excited to host the 4th annual Spring Symposium titled “Flex Your Knowledge: Muscle in Cerebral Palsy from Basic Science to Clinical Application," virtually on Friday, May 29, 2026. The recordings will be available for purchase on-demand from June 2, 2026 - July 14, 2026.
Registration Opens: March 2026
Live (virtual) Date: May 29, 2026
On-Demand Opens: June 2, 2026
Registration Closes: July 14, 2026
On-Demand Closes: July 14, 2026
Registration is required to access the on-demand recordings.
Registration Prices:
AACPDM Member: $99
Non-AACPDM Member: $199
Course Information
Summary:
The 2026 ACPDM Spring Symposium will introduce cutting-edge advancements in cerebral palsy (CP) muscle biology to the practicing clinician. An international multi-disciplinary panel of experts from basic science and clinical disciplines will guide the participants through a journey from the microscopic to the macroscopic, from the cutting-edge to the clinically-relevant. The morning session will compare and contrast typical muscle and muscle in individuals with CP. The afternoon session will focus on imaging modalities for muscle, changes to CP muscle that occur with treatment, and how advancements in CP muscle biology may change your practice. It’s sure to be a Spring Symposium that will get you pumped!
Learning Objectives:
Upon completion of this presentation, participants will be able to
- Understand the normal structure and function of skeletal muscle
- Recognize the adaptive changes of skeletal muscle in typically developing individuals to strength and conditioning
- Identify the changes that occur to skeletal muscle in individuals with cerebral palsy at the macroscopic, microscopic, and biochemical levels
- Better understand the natural history of muscle contracture development in individuals with cerebral palsy
- Identify how advancements in muscle biology could impact clinical decision making for individuals with cerebral palsy
Course Outline:
Morning Session: May 29, 2026 at 10:00am - 12:00pm CT

Afternoon Session: May 29, 2026 at 2:00pm - 4:00pm CT

CME/CEU Information
CME/CEU will be available through the course's platform (Blue Sky).
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy for Cerebral Palsy and Development Medicine. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163
Physicians (ACCME) Credit Designation
This activity is under review.
Speakers:
![]() |
Lucas Smith, PhD
|
![]() |
Noelle Moreau, PhD, PT
|
![]() |
Sudarshan Dayanidhi, PhD, PT
|
![]() |
Andrea Domenighetti, PhD, MBA Andrea “Andy” Domenighetti, PhD, MBA, is a Research Scientist and Principal Investigator of the Translational Biomedicine Lab at Shirley Ryan AbilityLab in Chicago. He is a translational biologist whose work focuses on the cellular and tissue mechanisms that drive skeletal muscle dysfunction in neuromuscular and rehabilitation populations, with particular emphasis on cerebral palsy (CP). His research addresses muscle contractures and pathological remodeling, aiming to clarify how muscle biology changes across development and aging in CP and how these changes relate to function and clinical outcomes. Dr. Domenighetti’s program integrates human biospecimens, clinically grounded study designs, and advanced molecular profiling approaches to map disease-relevant cell states and regulatory pathways. He also works closely with multidisciplinary clinical and research teams to bridge biological discovery with clinical translation, including biomarker development and therapeutic strategies to improve recovery in stroke, spinal cord injury, and CP. He has authored peer-reviewed publications spanning cardiovascular, neuromuscular and musculoskeletal biology and currently leads collaborative projects focused on CP muscle biology and novel interventions to address progressive musculoskeletal and neurological complications.
|
![]() |
Jason Howard, MD
|
![]() |
Eva Pontén, MD, PhD Eva Pontén, MD, PhD is an Associate Professor and a specialist in orthopedic surgery and hand surgeon at the Department of Pediatric Orthopedic Surgery, Karolinska University Hospital in Stockholm, and has an assignment as Karolinska University Hospital Chief Physician. Her clinical practice focuses mainly on cerebral palsy (upper and lower limb), spina bifida, arthrogryposis, limb deficiencies, developmental dysplasia of the hip (DDH), and trauma. In her research, she focuses mainly on cerebral palsy, with particular interest in muscle physiology, morphology, and function, as well as treatment strategies including the use of botulinum toxin. Her work seeks to deepen understanding of neuromuscular impairments and translate scientific insights into improved therapeutic interventions. She also studies gait and standing in spina bifida, arthrogryposis, bladder exstrophy and limb deficiencies. Dr. Pontén is actively involved in teaching and mentoring the next generation of surgeons and researchers, and she contributes regularly to national and international scientific forums.
|
![]() |
Ferdinand von Walden, MD, PhD |
Individual Cancellation Policy
Cancellation Policy:
All requests for cancellation must be received in writing by May 28, 2026. A 75% refund will be granted for requests received before this date. No refunds will be granted after May 28, 2026. All refunds will be processed after the course takes place.
Provider Cancellation Policy:
Cancellations of the Spring Courses activities by the AACPDM will result in all pre-registered attendees receiving a 100% refund.










